Impact of A2 milk versus conventional milk on intestinal health: a proof-of-concept study in Irritable Bowel Syndrome patients

Completed

• Conditions: Irritable Bowel Syndrome; 10017977

• Registration Number: NL-OMON52571
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Trial ended prematurely

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-06-05
• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Age between 18-70 years
Based on Rome IV criteria, IBS-C or IBS-D predominant
Indication that dietary components trigger GI symptoms

Exclusion Criteria

Abdominal surgery interfering with gastrointestinal function
Lactose intolerance
Cow's milk allergy
Use of antibiotics in the 90 days prior to the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Overall GI discomfort </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Single GI symptoms<br /><br>Stool characteristics (frequency and consistency)<br /><br>BCM-7 in blood<br /><br>Effect of baseline characteristics on objectives </p><br>